TELO (telomirpharma.com) Volume dodolan mangsa ngarep perusahaan

Simbol lan logo merek Telomir Pharmaceuticals (TELO)

Telomir Pharmaceuticals (TELO) develops telomere length correction methods to combat genetic pathologies, including the veterinary sector and fibrosis. The company's projected sales dynamics confirm the resilience of its strategy, where 0.00 determines the current value of the metric. Regeneration patents create a high barrier to entry, while strict FDA oversight and speculative investor interest drive the development of this closed ecosystem.

TELO - Volume dodolan sing dikarepake perusahaan Telomir Pharmaceuticals ing rentang 21.02.2024 - 18.11.2026

Ringkesan rincian data analitis Telomir Pharmaceuticals Corp (TELO)

Analisis fundamental perusahaan:Telomir Pharmaceuticals Inc
Produk mawa merek Telomir Pharma

Telomir Pharmaceuticals focuses on innovations in gerontology and cellular senescence therapy. This indicator aggregates data on new contracts to calculate expected cash flows. By analyzing the company's projected sales volume, the investor assesses the impact of corporate news on capitalization. This metric's trend reflects the ability of scientific breakthroughs to convert into actual revenue, allowing for the verification of the asset's market value stability.

Pesaing utama

Prakiraan volume dodolan HLN|KVUE (Kenvue Inc) - Pendapatan mangsa ngarep perusahaan|Verona Pharma Corp - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan MENS (Jyong Biotech Ltd)|ligand.com - Prakiraan volume dodolan|amneal.com (AMRX) - Volume dodolan mangsa ngarep perusahaan|Perrigo (PRGO) - Prakiraan pendapatan perusahaan|ALVO (Alvotech S.A.) - Prakiraan pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan LQDA|Prakiraan volume dodolan Galapagos Corp|Prakiraan pendapatan perusahaan ANI Pharma (ANIP)|Prakiraan volume dodolan MannKind Corporation (MNKD)|Prakiraan pendapatan perusahaan Amphastar Pharmaceuticals Inc AMPH|Prakiraan volume dodolan Pacira PCRX|ARS Pharmaceuticals Inc - Prakiraan volume dodolan|TBPH - Prakiraan volume dodolan|AQST (Aquestive Therapeutics) - Volume dodolan mangsa ngarep perusahaan|scPharmaceuticals, Inc. (SCPH) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan TECX|Prakiraan volume dodolan Tonix Pharma|Volume dodolan mangsa ngarep perusahaan SXTC (SXT Pharmaceuticals)|EPRX: Pendapatan sing dikarepake perusahaan|BioHarvest Sciences - Volume dodolan mangsa ngarep perusahaan|EXOZ: Prakiraan pendapatan perusahaan|ORMP - Prakiraan pendapatan perusahaan|ENTX: Prakiraan pendapatan perusahaan|HYFT: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan ABVC BioPharma Inc|CPIX (Cumberland Corp) - Prakiraan volume dodolan|Prakiraan volume dodolan quantumbiopharma.com|Prakiraan volume dodolan FGEN|Dodolan mangsa ngarep perusahaan Rani Therapeutics Holdings, Inc.|Prakiraan pendapatan perusahaan Synergy CHC Corp. SNYR|Prakiraan volume dodolan rallybio.com RLYB|Lexaria Bioscience Corp. - Prakiraan volume dodolan|PULM: Prakiraan pendapatan perusahaan|PTHL (ftzy.com.cn) - Volume dodolan mangsa ngarep perusahaan|APM: Prakiraan volume pendapatan perusahaan|LYRA (Lyra Therapeutics Inc) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan IBO (Impact BioMedical)|Volume dodolan mangsa ngarep perusahaan TNFA (TNF Pharmaceuticals)|Prakiraan volume dodolan cbdMD Corp (YCBD)|Prakiraan volume dodolan PRFX (PainReform)|Dodolan mangsa ngarep perusahaan Auris Medical (CYTO)|LIPO - Prakiraan pendapatan perusahaan|Optinose (OPTN) - Volume dodolan mangsa ngarep perusahaan|Pieris (PIRS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan PROC (Procaps Group S.A.)|Volume dodolan mangsa ngarep perusahaan PTPI|QLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan acelyrin.com (SLRN)|TFFP (TFF Pharma) - Pendapatan mangsa ngarep perusahaan